IHE vs. FPHAX
Compare and contrast key facts about iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
IHE vs. FPHAX - Performance Comparison
Loading graphics...
IHE vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 3.70% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.39% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
Returns By Period
In the year-to-date period, IHE achieves a 3.70% return, which is significantly higher than FPHAX's 0.39% return. Over the past 10 years, IHE has underperformed FPHAX with an annualized return of 8.20%, while FPHAX has yielded a comparatively higher 11.27% annualized return.
IHE
- 1D
- 1.15%
- 1M
- -3.66%
- YTD
- 3.70%
- 6M
- 18.16%
- 1Y
- 32.13%
- 3Y*
- 16.43%
- 5Y*
- 10.17%
- 10Y*
- 8.20%
FPHAX
- 1D
- 3.02%
- 1M
- -5.31%
- YTD
- 0.39%
- 6M
- 13.18%
- 1Y
- 34.09%
- 3Y*
- 17.36%
- 5Y*
- 12.54%
- 10Y*
- 11.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IHE vs. FPHAX - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is lower than FPHAX's 0.75% expense ratio.
Return for Risk
IHE vs. FPHAX — Risk / Return Rank
IHE
FPHAX
IHE vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IHE | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.59 | 1.33 | +0.27 |
Sortino ratioReturn per unit of downside risk | 2.20 | 1.84 | +0.36 |
Omega ratioGain probability vs. loss probability | 1.29 | 1.24 | +0.05 |
Calmar ratioReturn relative to maximum drawdown | 2.52 | 2.50 | +0.02 |
Martin ratioReturn relative to average drawdown | 7.93 | 7.03 | +0.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IHE | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.59 | 1.33 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.64 | 0.71 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.45 | 0.64 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.53 | -0.03 |
Correlation
The correlation between IHE and FPHAX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
IHE vs. FPHAX - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.70%, less than FPHAX's 5.66% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.70% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.66% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
IHE vs. FPHAX - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, roughly equal to the maximum FPHAX drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for IHE and FPHAX.
Loading graphics...
Drawdown Indicators
| IHE | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -38.26% | +0.06% |
Max Drawdown (1Y)Largest decline over 1 year | -10.58% | -11.00% | +0.42% |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | -28.82% | +12.79% |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | -28.82% | -0.77% |
Current DrawdownCurrent decline from peak | -4.22% | -7.10% | +2.88% |
Average DrawdownAverage peak-to-trough decline | -7.95% | -9.21% | +1.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.36% | 4.30% | -0.94% |
Volatility
IHE vs. FPHAX - Volatility Comparison
The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 5.91%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 6.89%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IHE | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.91% | 6.89% | -0.98% |
Volatility (6M)Calculated over the trailing 6-month period | 12.12% | 14.30% | -2.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.70% | 23.52% | -2.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.95% | 17.74% | -1.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.11% | 17.81% | +0.30% |